Literature DB >> 10476613

Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia.

E Beinder1, M G Mohaupt, D Schlembach, T Fischer, R B Sterzel, N Lang, C Baylis.   

Abstract

OBJECTIVE: We investigated the hypothesis that changes in blood flow in the uteroplacental and fetoplacental circulation in preeclampsia are associated with an abnormality of placental or uterine placental bed nitric oxide (NO) synthesis.
METHODS: We measured pulsatility indices on Doppler waveform analysis from uterine and umbilical arteries in 20 patients with preeclampsia and 14 healthy pregnant controls before elective cesarean section. During cesarean section, biopsies from the uterine placental bed and the placenta were taken and the nitric oxide synthase (NOS) activity was measured by the [3H] L-arginine-[3H] L-citrulline conversion assay in these samples.
RESULTS: The NOS activity was significantly lower in the uterine placental bed in comparison to the placental tissue (p < 0.01). Placental NOS activity was similar between patients with preeclampsia and healthy controls and in the groups with either a pathological or a normal Doppler flow in the umbilical artery. In the uterine placental bed however, NOS activity from patients with preeclampsia was significantly lower (p < 0.01), whereas the blood flow resistance in the uterine arteries was elevated (p < 0.01) in comparison to healthy controls.
CONCLUSIONS: Our data show that pathological Doppler waveforms in the uterine arteries of patients with preeclampsia are paralleled by diminished NOS activity in the uterine placental bed. Therefore, the compromised NO production in the uterine placental bed may play an important role in the impaired uteroplacental blood flow and potentially in some pathological features of preeclampsia such as intervillous thrombosis formation and fetal growth retardation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476613     DOI: 10.3109/10641959909023071

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  7 in total

1.  Impact of fetal versus perinatal hypoxia on sex differences in childhood outcomes: developmental timing matters.

Authors:  Michael Anastario; Carolyn M Salafia; Garrett Fitzmaurice; Jill M Goldstein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-17       Impact factor: 4.328

2.  Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies.

Authors:  Barbara Schiessl; Ioannis Mylonas; Peer Hantschmann; Christina Kuhn; Sandra Schulze; Susi Kunze; Klaus Friese; Udo Jeschke
Journal:  J Histochem Cytochem       Date:  2005-06-27       Impact factor: 2.479

Review 3.  Pathophysiology of pre-eclampsia: update on the role of nitric oxide.

Authors:  Maki Kashiwagi; Roland Zimmermann; Ernst Beinder
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

4.  Resveratrol inhibits trophoblast apoptosis through oxidative stress in preeclampsia-model rats.

Authors:  Yanfen Zou; Qing Zuo; Shiyun Huang; Xiang Yu; Ziyan Jiang; Shan Zou; Mingsong Fan; Lizhou Sun
Journal:  Molecules       Date:  2014-12-09       Impact factor: 4.411

Review 5.  The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia-Review.

Authors:  Weronika Dymara-Konopka; Marzena Laskowska
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

6.  A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies.

Authors:  Marzena Laskowska; Katarzyna Laskowska; Mahfoz Terbosh; Jan Oleszczuk
Journal:  Med Sci Monit       Date:  2013-06-05

7.  Comparison of Diagnostic Values of Maternal Arginine Concentration for Different Pregnancy Complications: A Systematic Review and Meta-Analysis.

Authors:  Lianbin Xu; Jia Zeng; Huanan Wang; Hongyun Liu
Journal:  Biomedicines       Date:  2022-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.